Helius Medical Technologies Inc Class A (HSDT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Helius Medical Technologies Inc Class A (HSDT) has a cash flow conversion efficiency ratio of 0.027x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-4.04 Million) by net assets ($-152.39 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See HSDT cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Helius Medical Technologies Inc Class A - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Helius Medical Technologies Inc Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Helius Medical Technologies Inc Class A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Helius Medical Technologies Inc Class A ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Tainet Communication System
TWO:4905
|
0.016x |
|
Great Boulder Resources Ltd
AU:GBR
|
-0.022x |
|
Austin Engineering Ltd
AU:ANG
|
0.047x |
|
Bina Puri Holdings Bhd
KLSE:5932
|
-0.332x |
|
Principal Real Estate Income Closed Fund
NYSE:PGZ
|
0.029x |
|
Cape EMS Berhad
KLSE:5311
|
-0.093x |
|
Ariadne Australia Ltd
AU:ARA
|
0.038x |
|
GBM Resources Limited
AU:GBM
|
-0.031x |
Annual Cash Flow Conversion Efficiency for Helius Medical Technologies Inc Class A (2013–2024)
The table below shows the annual cash flow conversion efficiency of Helius Medical Technologies Inc Class A from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Helius Medical Technologies Inc Class A stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.06 Million | $-11.04 Million | -10.426x | -135.22% |
| 2023-12-31 | $2.35 Million | $-10.42 Million | -4.432x | -152.47% |
| 2022-12-31 | $8.15 Million | $-14.31 Million | -1.756x | -47.60% |
| 2021-12-31 | $11.26 Million | $-13.39 Million | -1.189x | +60.78% |
| 2020-12-31 | $3.87 Million | $-11.74 Million | -3.032x | +15.74% |
| 2019-12-31 | $5.83 Million | $-21.00 Million | -3.599x | -80.74% |
| 2018-12-31 | $9.85 Million | $-19.62 Million | -1.991x | -177.17% |
| 2017-12-31 | $-7.49 Million | $-19.32 Million | 2.580x | -99.47% |
| 2016-12-31 | $-16.19K | $-7.94 Million | 490.176x | -0.01% |
| 2015-12-31 | $-16.19K | $-7.94 Million | 490.206x | +12020.05% |
| 2014-12-31 | $-1.56 Million | $-6.32 Million | 4.045x | +210.83% |
| 2013-12-31 | $-267.98K | $-348.70K | 1.301x | -- |
About Helius Medical Technologies Inc Class A
Solana Company operates as a listed digital asset treasury. It enhances SOL per share on the commercially viable blockchain for decentralized finance and consumer applications. The company is headquartered in Newtown, Pennsylvania.